Sign in
Active, not recruitingNo phase

A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities

Key facts

Who runs it
University of Minnesota
Where
Minneapolis and Rochester, United StatesSee the 3 sites
Trial code
Status
Active, not recruiting
People taking part
700 people enrolled
Started
5 May 2023
Expected to end
31 Mar 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Longitudinal Proactive Outreach (LPO).
  • Ask-Advice-Connect (AAC)
Record updated
13 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey
  • Currently smoke >1 cigarette over the past 30 days
  • Must have address or telephone number in the electronic health record

Who cannot take part

  • Electronic health record documented cognitive impairment or legal guardianship
  • Patients who have opted out of reserach studies

Where in United States

  • Hennepin HealthcareMinneapolis, United States
  • University of MinnesotaMinneapolis, United States
  • Mayo Clinic Health SystemRochester, United States

About the trial

What the trial wants to find out

This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.

The 2 groups in the trial

  • Enhanced Usual Care: Ask-Advice-Connect (AAC)Existing treatment, for comparison

    AAC participants will receive care through their primary care provider as usual (with the caveat that providers in the clinics will be trained to provide AAC). AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.

    Treatment: Ask-Advice-Connect (AAC)

  • AAC + Longitudinal Proactive Outreach (LPO)Treatment being tested

    AAC+LPO participants will receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment. AAC includes enhanced access to State Quitline and Nicotine Replacement Therapy.

    Treatment: Longitudinal Proactive Outreach (LPO). and Ask-Advice-Connect (AAC)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
13 April 2026